Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-01 Sale | 2024-10-02 9:54 pm | ROCKWELL MEDICAL INC. | RMTI | Strobeck Mark President and CEO | 2,163 | $3.6852 | $7,971 | 147,201 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-17 Tax Withholding | 2024-03-19 4:33 pm | N/A N/A | ROCKWELL MEDICAL INC. | RMTI | Strobeck Mark President and CEO | 6,101 | $1.4 | 149,364 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:34 pm | N/A 2034-03-14 | ROCKWELL MEDICAL INC. | RMTI | Strobeck Mark President and CEO | 241,560 | $0 | 297,025 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-25 6:03 pm | N/A 2033-08-23 | WINDTREE THERAPEUTICS INC | WINT | Strobeck Mark Director | 5,750 | $0 | 5,750 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-21 6:36 pm | N/A 2033-03-17 | ROCKWELL MEDICAL INC. | RMTI | Strobeck Mark President and CEO | 132,570 | $0 | 132,570 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-05 4:37 pm | N/A 2032-07-01 | ROCKWELL MEDICAL INC. | RMTI | Strobeck Mark President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 8:56 pm | N/A 2030-03-04 | Assertio Holdings Inc. | ASRT | Strobeck Mark EVP & Chief Operating Officer | 539,599 | $0 | 539,599 (Direct) | View |
| 2020-05-20 Disposition | 2020-05-21 4:33 pm | N/A 2030-03-04 | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 297,264 | $0 | 0 (Direct) | View |
| 2020-03-26 Exercise | 2020-03-26 6:25 pm | N/A N/A | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 62,000 | $0 | 44,962 (Direct) | View |
| 2020-03-26 Exercise | 2020-03-26 6:25 pm | N/A N/A | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 62,000 | $1.6 | 44,962 (Direct) | View |
| 2020-03-26 Tax Withholding | 2020-03-26 6:25 pm | N/A N/A | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 17,038 | $1.6 | 44,962 (Direct) | View |
| 2020-03-04 Option Award | 2020-03-05 8:46 pm | N/A 2030-03-04 | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 196,200 | $0 | 196,200 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-02 8:54 pm | N/A N/A | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 20,812 | $1.5 | 54,923 (Direct) | View |
| 2020-03-01 Exercise | 2020-03-02 8:54 pm | N/A N/A | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 75,735 | $0 | 54,923 (Direct) | View |
| 2020-03-01 Exercise | 2020-03-02 8:54 pm | N/A N/A | Zyla Life Sciences | ZCOR | Strobeck Mark Chief Operating Officer | 75,735 | $1.5 | 54,923 (Direct) | View |